Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin

Manca et al., Viruses, doi:10.3390/v16050665
Apr 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
24th treatment shown to reduce risk in July 2021, now with p = 0.0031 from 11 studies.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 111 treatments. c19early.org
In Vitro study showing that esters of cinnamic acids with quercetin, particularly ester 7, inhibit SARS-CoV-2 and hCoV-OC43 coronavirus infection in Vero-76 and Vero E6 cells. Mechanism of action studies suggest ester 7 may inhibit coronavirus infection by reducing viral attachment to host cells and blocking viral endocytosis. Authors propose these quercetin-cinnamic acid conjugates as potential coronavirus antivirals worthy of further investigation.
Bioavailability. Quercetin has low bioavailability and studies typically use advanced formulations to improve bioavailability which may be required to reach therapeutic concentrations.
73 preclinical studies support the efficacy of quercetin for COVID-19:
In Silico studies predict inhibition of SARS-CoV-2, or minimization of side effects, with quercetin or metabolites via binding to the spikeA,3,9,10,22,24,25,30,38,39,41,42,62-64, MproB,3,7,9,11,13,15,17,18,20,23,24,30,34,36-38,42,43,45,63-65, RNA-dependent RNA polymeraseC,1,3,9,32,64, PLproD,3,37,45, ACE2E,22,23,28,37,41,63, TMPRSS2F,22, nucleocapsidG,3, helicaseH,3,29,34, endoribonucleaseI,39, NSP16/10J,6, cathepsin LK,26, Wnt-3L,22, FZDM,22, LRP6N,22, ezrinO,40, ADRPP,38, NRP1Q,41, EP300R,16, PTGS2S,23, HSP90AA1T,16,23, matrix metalloproteinase 9U,31, IL-6V,21,35, IL-10W,21, VEGFAX,35, and RELAY,35 proteins. In Vitro studies demonstrate inhibition of the MproB,15,46,51,59 protein, and inhibition of spike-ACE2 interactionZ,47. In Vitro studies demonstrate efficacy in Calu-3AA,50, A549AB,21, HEK293-ACE2+AC,58, Huh-7AD,25, Caco-2AE,49, Vero E6AF,19,42,49, mTECAG,52, and RAW264.7AH,52 cells. Animal studies demonstrate efficacy in K18-hACE2 miceAI,55, db/db miceAJ,52,61, BALB/c miceAK,60, and rats66. Quercetin reduced proinflammatory cytokines and protected lung and kidney tissue against LPS-induced damage in mice60, inhibits LPS-induced cytokine storm by modulating key inflammatory and antioxidant pathways in macrophages5, and inhibits SARS-CoV-2 ORF3a ion channel activity, which contributes to viral pathogenicity and cytotoxicity54.
a. The trimeric spike (S) protein is a glycoprotein that mediates viral entry by binding to the host ACE2 receptor, is critical for SARS-CoV-2's ability to infect host cells, and is a target of neutralizing antibodies. Inhibition of the spike protein prevents viral attachment, halting infection at the earliest stage.
b. The main protease or Mpro, also known as 3CLpro or nsp5, is a cysteine protease that cleaves viral polyproteins into functional units needed for replication. Inhibiting Mpro disrupts the SARS-CoV-2 lifecycle within the host cell, preventing the creation of new copies.
c. RNA-dependent RNA polymerase (RdRp), also called nsp12, is the core enzyme of the viral replicase-transcriptase complex that copies the positive-sense viral RNA genome into negative-sense templates for progeny RNA synthesis. Inhibiting RdRp blocks viral genome replication and transcription.
d. The papain-like protease (PLpro) has multiple functions including cleaving viral polyproteins and suppressing the host immune response by deubiquitination and deISGylation of host proteins. Inhibiting PLpro may block viral replication and help restore normal immune responses.
e. The angiotensin converting enzyme 2 (ACE2) protein is a host cell transmembrane protein that serves as the cellular receptor for the SARS-CoV-2 spike protein. ACE2 is expressed on many cell types, including epithelial cells in the lungs, and allows the virus to enter and infect host cells. Inhibition may affect ACE2's physiological function in blood pressure control.
f. Transmembrane protease serine 2 (TMPRSS2) is a host cell protease that primes the spike protein, facilitating cellular entry. TMPRSS2 activity helps enable cleavage of the spike protein required for membrane fusion and virus entry. Inhibition may especially protect respiratory epithelial cells, buy may have physiological effects.
g. The nucleocapsid (N) protein binds and encapsulates the viral genome by coating the viral RNA. N enables formation and release of infectious virions and plays additional roles in viral replication and pathogenesis. N is also an immunodominant antigen used in diagnostic assays.
h. The helicase, or nsp13, protein unwinds the double-stranded viral RNA, a crucial step in replication and transcription. Inhibition may prevent viral genome replication and the creation of new virus components.
i. The endoribonuclease, also known as NendoU or nsp15, cleaves specific sequences in viral RNA which may help the virus evade detection by the host immune system. Inhibition may hinder the virus's ability to mask itself from the immune system, facilitating a stronger immune response.
j. The NSP16/10 complex consists of non-structural proteins 16 and 10, forming a 2'-O-methyltransferase that modifies the viral RNA cap structure. This modification helps the virus evade host immune detection by mimicking host mRNA, making NSP16/10 a promising antiviral target.
k. Cathepsin L is a host lysosomal cysteine protease that can prime the spike protein through an alternative pathway when TMPRSS2 is unavailable. Dual targeting of cathepsin L and TMPRSS2 may maximize disruption of alternative pathways for virus entry.
l. Wingless-related integration site (Wnt) ligand 3 is a host signaling molecule that activates the Wnt signaling pathway, which is important in development, cell growth, and tissue repair. Some studies suggest that SARS-CoV-2 infection may interfere with the Wnt signaling pathway, and that Wnt3a is involved in SARS-CoV-2 entry.
m. The frizzled (FZD) receptor is a host transmembrane receptor that binds Wnt ligands, initiating the Wnt signaling cascade. FZD serves as a co-receptor, along with ACE2, in some proposed mechanisms of SARS-CoV-2 infection. The virus may take advantage of this pathway as an alternative entry route.
n. Low-density lipoprotein receptor-related protein 6 is a cell surface co-receptor essential for Wnt signaling. LRP6 acts in tandem with FZD for signal transduction and has been discussed as a potential co-receptor for SARS-CoV-2 entry.
o. The ezrin protein links the cell membrane to the cytoskeleton (the cell's internal support structure) and plays a role in cell shape, movement, adhesion, and signaling. Drugs that occupy the same spot on ezrin where the viral spike protein would bind may hindering viral attachment, and drug binding could further stabilize ezrin, strengthening its potential natural capacity to impede viral fusion and entry.
p. The Adipocyte Differentiation-Related Protein (ADRP, also known as Perilipin 2 or PLIN2) is a lipid droplet protein regulating the storage and breakdown of fats in cells. SARS-CoV-2 may hijack the lipid handling machinery of host cells and ADRP may play a role in this process. Disrupting ADRP's interaction with the virus may hinder the virus's ability to use lipids for replication and assembly.
q. Neuropilin-1 (NRP1) is a cell surface receptor with roles in blood vessel development, nerve cell guidance, and immune responses. NRP1 may function as a co-receptor for SARS-CoV-2, facilitating viral entry into cells. Blocking NRP1 may disrupt an alternative route of viral entry.
r. EP300 (E1A Binding Protein P300) is a transcriptional coactivator involved in several cellular processes, including growth, differentiation, and apoptosis, through its acetyltransferase activity that modifies histones and non-histone proteins. EP300 facilitates viral entry into cells and upregulates inflammatory cytokine production.
s. Prostaglandin G/H synthase 2 (PTGS2, also known as COX-2) is an enzyme crucial for the production of inflammatory molecules called prostaglandins. PTGS2 plays a role in the inflammatory response that can become severe in COVID-19 and inhibitors (like some NSAIDs) may have benefits in dampening harmful inflammation, but note that prostaglandins have diverse physiological functions.
t. Heat Shock Protein 90 Alpha Family Class A Member 1 (HSP90AA1) is a chaperone protein that helps other proteins fold correctly and maintains their stability. HSP90AA1 plays roles in cell signaling, survival, and immune responses. HSP90AA1 may interact with numerous viral proteins, but note that it has diverse physiological functions.
u. Matrix metalloproteinase 9 (MMP9), also called gelatinase B, is a zinc-dependent enzyme that breaks down collagen and other components of the extracellular matrix. MMP9 levels increase in severe COVID-19. Overactive MMP9 can damage lung tissue and worsen inflammation. Inhibition of MMP9 may prevent excessive tissue damage and help regulate the inflammatory response.
v. The interleukin-6 (IL-6) pro-inflammatory cytokine (signaling molecule) has a complex role in the immune response and may trigger and perpetuate inflammation. Elevated IL-6 levels are associated with severe COVID-19 cases and cytokine storm. Anti-IL-6 therapies may be beneficial in reducing excessive inflammation in severe COVID-19 cases.
w. The interleukin-10 (IL-10) anti-inflammatory cytokine helps regulate and dampen immune responses, preventing excessive inflammation. IL-10 levels can also be elevated in severe COVID-19. IL-10 could either help control harmful inflammation or potentially contribute to immune suppression.
x. Vascular Endothelial Growth Factor A (VEGFA) promotes the growth of new blood vessels (angiogenesis) and has roles in inflammation and immune responses. VEGFA may contribute to blood vessel leakiness and excessive inflammation associated with severe COVID-19.
y. RELA is a transcription factor subunit of NF-kB and is a key regulator of inflammation, driving pro-inflammatory gene expression. SARS-CoV-2 may hijack and modulate NF-kB pathways.
z. The interaction between the SARS-CoV-2 spike protein and the human ACE2 receptor is a primary method of viral entry, inhibiting this interaction can prevent the virus from attaching to and entering host cells, halting infection at an early stage.
aa. Calu-3 is a human lung adenocarcinoma cell line with moderate ACE2 and TMPRSS2 expression and SARS-CoV-2 susceptibility. It provides a model of the human respiratory epithelium, but many not be ideal for modeling early stages of infection due to the moderate expression levels of ACE2 and TMPRSS2.
ab. A549 is a human lung carcinoma cell line with low ACE2 expression and SARS-CoV-2 susceptibility. Viral entry/replication can be studied but the cells may not replicate all aspects of lung infection.
ac. HEK293-ACE2+ is a human embryonic kidney cell line engineered for high ACE2 expression and SARS-CoV-2 susceptibility.
ad. Huh-7 cells were derived from a liver tumor (hepatoma).
ae. Caco-2 cells come from a colorectal adenocarcinoma (cancer). They are valued for their ability to form a polarized cell layer with properties similar to the intestinal lining.
af. Vero E6 is an African green monkey kidney cell line with low/no ACE2 expression and high SARS-CoV-2 susceptibility. The cell line is easy to maintain and supports robust viral replication, however the monkey origin may not accurately represent human responses.
ag. mTEC is a mouse tubular epithelial cell line.
ah. RAW264.7 is a mouse macrophage cell line.
ai. A mouse model expressing the human ACE2 receptor under the control of the K18 promoter.
aj. A mouse model of obesity and severe insulin resistance leading to type 2 diabetes due to a mutation in the leptin receptor gene that impairs satiety signaling.
ak. A mouse model commonly used in infectious disease and cancer research due to higher immune response and susceptibility to infection.
Manca et al., 24 Apr 2024, peer-reviewed, 14 authors. Contact: mancavaleria26@gmail.com (corresponding author), vanessa.palmas@unica.it, aldomanzin@unica.it, annalisa.chianese@unicampania.it, carla.zannella@unicampania.it, mariavittoriamorone@gmail.com, massimiliano.galdiero@unicampania.it, federicaetzi@gmail.com, davide.moi2@gmail.com, gsarais@unica.it, vonnis@unica.it, fsecci@unica.it, gabriele.serreli@unica.it, g.sanna@unica.it.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperQuercetinAll
Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin
Valeria Manca, Annalisa Chianese, Vanessa Palmas, Federica Etzi, Carla Zannella, Davide Moi, Francesco Secci, Gabriele Serreli, Giorgia Sarais, Maria Vittoria Morone, Massimiliano Galdiero, Valentina Onnis, Aldo Manzin, Giuseppina Sanna
Viruses, doi:10.3390/v16050665
Severe acute respiratory syndrome-related Coronavirus 2 (SARS-CoV-2) has infected more than 762 million people to date and has caused approximately 7 million deaths all around the world, involving more than 187 countries. Although currently available vaccines show high efficacy in preventing severe respiratory complications in infected patients, the high number of mutations in the S proteins of the current variants is responsible for the high level of immune evasion and transmissibility of the virus and the reduced effectiveness of acquired immunity. In this scenario, the development of safe and effective drugs of synthetic or natural origin to suppress viral replication and treat acute forms of COVID-19 remains a valid therapeutic challenge. Given the successful history of flavonoids-based drug discovery, we developed esters of substituted cinnamic acids with quercetin to evaluate their in vitro activity against a broad spectrum of Coronaviruses. Interestingly, two derivatives, the 3,4-methylenedioxy 6 and the ester of acid 7, have proved to be effective in reducing OC43-induced cytopathogenicity, showing interesting EC50s profiles. The ester of synaptic acid 7 in particular, which is not endowed with relevant cytotoxicity under any of the tested conditions, turned out to be active against OC43 and SARS-CoV-2, showing a promising EC 50 . Therefore, said compound was selected as the lead object of further analysis. When tested in a yield reduction, assay 7 produced a significant dose-dependent reduction in viral titer. However, the compound was not virucidal, as exposure to high concentrations of it did not affect viral infectivity, nor did it affect hCoV-OC43 penetration into pre-treated host cells. Additional studies on the action mechanism have suggested that our derivative may inhibit viral endocytosis by reducing viral attachment to host cells.
Conflicts of Interest: The authors declare no conflict of interest.
References
Adisakwattana, Pongsuwan, Wungcharoen, Yibchok-Anun, In Vitro Effects of Cinnamic Acid Derivatives on Protein Tyrosine Phosphatase 1B, J. Enzym. Inhib. Med. Chem, doi:10.3109/14756366.2012.715286
Ahmad, Kaleem, Ahmed, Shafiq, Therapeutic potential of flavonoids and their mechanism of action against microbial and viral infections-A review, Food Res. Int, doi:10.1016/j.foodres.2015.06.021
Amano, Yamashita, Kasai, Hori, Miyasato et al., Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress, Antivir. Res, doi:10.1016/j.antiviral.2017.07.018
Antonopoulou, Sapountzaki, Rova, Christakopoulos, Ferulic acid from plant biomass: A phytochemical with promising antiviral properties, Front. Nutr, doi:10.3389/fnut.2021.777576
Badshah, Faisal, Muhammad, Poulson, Emwas et al., Antiviral activities of flavonoids, Biomed. Pharmacother, doi:10.1016/j.biopha.2021.111596
Baj, Karakuła-Juchnowicz, Teresi Ński, Buszewicz, Ciesielka et al., COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge, J. Clin. Med, doi:10.3390/jcm9061753
Balboni, Congiu, Onnis, Maresca, Scozzafava et al., Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins, Bioorg. Med. Chem. Lett, doi:10.1016/j.bmcl.2012.03.071
Bian, Guo, Majeed, Zhu, Guo et al., Ferulic acid renders protection to HEK293 cells against oxidative damage and apoptosis induced by hydrogen peroxide, Vitr. Cell. Dev. Biol.-Anim, doi:10.1007/s11626-015-9876-0
Chaachouay, Zidane, Plant-Derived Natural Products: A Source for Drug Discovery and Development, Drugs Drug Candidates, doi:10.3390/ddc3010011
Chen, Li, Pan, Lao, Xu et al., Cinnamic acid inhibits Zika virus by inhibiting RdRp activity, Antivir. Res, doi:10.1016/j.antiviral.2021.105117
Citarella, Dimasi, Moi, Passarella, Scala et al., Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives, Biomolecules, doi:10.3390/biom13091339
Citarella, Moi, Pedrini, Pérez-Peña, Pieraccini et al., Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses, Org. Biomol. Chem, doi:10.1039/D3OB00381G
Cui, Xiao, Xu, Chen, Liu et al., Bioassay of ferulic acid derivatives as influenza neuraminidase inhibitors, Arch. Pharm, doi:10.1002/ardp.201900174
Detoma, Krishnamoorthy, Nam, Lee, Brender et al., Synthetic Flavonoids, Aminoisoflavones: Interaction and Reactivity with Metal-Free and Metal-Associated Amyloid-β Species, Chem. Sci, doi:10.1039/c4sc01531b
Dinda, Dinda, Dinda, Ghosh, Das, Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy, Eur. J. Med. Chem. Rep, doi:10.1016/j.ejmcr.2023.100125
Elebeedy, Elkhatib, Kandeil, Ghanem, Kutkat et al., Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights, RSC Adv, doi:10.1039/D1RA05268C
Fuzo, Martins, Fraga-Silva, Amstalden, Canassa De Leo et al., Celastrol: A lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion, Drug Dev. Res, doi:10.1002/ddr.21982
Gao, Yu, Guo, Kong, Gu et al., The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells, Cancer Cell Int, doi:10.1186/s12935-018-0595-y
Ibba, Carta, Madeddu, Caria, Serreli et al., Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative, Viruses, doi:10.3390/v13010058
Ibitoye, Ajiboye, Ferulic acid potentiates the antibacterial activity of quinolone-based antibiotics against Acinetobacter baumannii, Microb. Pathog, doi:10.1016/j.micpath.2018.11.033
Lalani, Poh, Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71), Viruses, doi:10.3390/v12020184
Lambruschini, Demori, El Rashed, Rovegno, Canessa et al., Synthesis, photoisomerization, antioxidant activity, and lipid Lowering effect of ferulic acid and feruloyl amides, Molecules, doi:10.3390/molecules26010089
Lan, Hou, Liu, Ding, Zhang et al., Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease, J. Enzym. Inhib. Med. Chem, doi:10.1080/14756366.2016.1256883
Liu, Wei, Li, Liu, Cao et al., Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents, Eur. J. Med. Chem, doi:10.1016/j.ejmech.2015.03.056
Mao, Wang, Chen, Yan, Xun et al., synthesis, antiviral activities of ferulic acid derivatives, Front. Pharmacol, doi:10.3389/fphar.2023.1133655
Montaser, Huttunen, Ibrahim, Huttunen, Astrocyte-targeted transporter-utilizing derivatives of ferulic acid can have multifunctional effects ameliorating inflammation and oxidative stress in the brain, Oxidative Med. Cell. Longev, doi:10.1155/2019/3528148
Nićiforović, Abramovič, Sinapic Acid and Its Derivatives: Natural Sources and Bioactivity, Compr. Rev. Food Sci. Food Saf, doi:10.1111/1541-4337.12041
Pavlíková, Caffeic Acid and Diseases-Mechanisms of Action, Int. J. Mol. Sci, doi:10.3390/ijms24010588
Peng, Cheng, Gong, Yuan, Zhao et al., Advances in the design and development of SARS-CoV-2 vaccines, Mil. Med. Res, doi:10.1186/s40779-021-00360-1
Sanna, Farci, Busonera, Murgia, La Colla et al., Antiviral properties from plants of the Mediterranean flora, Nat. Prod. Res, doi:10.1080/14786419.2014.1003187
Serreli, Le Sayec, Thou, Lacour, Diotallevi et al., Ferulic Acid Derivatives and Avenanthramides Modulate Endothelial Function through Maintenance of Nitric Oxide Balance in HUVEC Cells, Nutrients, doi:10.3390/nu13062026
Theodosis-Nobelos, Kourti, Tziona, Kourounakis, Rekka, Esters of some non-steroidal anti-inflammatory drugs with cinnamyl alcohol are potent lipoxygenase inhibitors with enhanced anti-inflammatory activity, Bioorg. Med. Chem. Lett, doi:10.1016/j.bmcl.2015.10.036
Theodosis-Nobelos, Papagiouvannis, Rekka, Ferulic, Sinapic, 3,4-Dimethoxycinnamic Acid and Indomethacin Derivatives with Antioxidant, Anti-Inflammatory and Hypolipidemic Functionality, Antioxidants, doi:10.3390/antiox12071436
Ullah, Munir, Badshah, Khan, Ghani et al., Important Flavonoids and Their Role as a Therapeutic Agent, Molecules, doi:10.3390/molecules25225243
V'kovski, Kratzel, Steiner, Stalder, Thiel, Coronavirus biology and replication: Implications for SARS-CoV, Nat. Rev. Microbiol, doi:10.1038/s41579-020-00468-6
Yin, Zhang, Li, Shi, Jin et al., Ferulic acid inhibits bovine endometrial epithelial cells against LPS-induced inflammation via suppressing NK-κB and MAPK pathway, Res. Vet. Sci, doi:10.1016/j.rvsc.2019.08.018
Zannella, Giugliano, Chianese, Buonocore, Vitale et al., Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1, Viruses, doi:10.3390/v13071263
Zhou, Xu, Zhao, Chen, Jin et al., Ferulic acid relaxed rat aortic, small mesenteric and coronary arteries by blocking voltage-gated calcium channel and calcium desensitization via dephosphorylation of ERK1/2 and MYPT1, Eur. J. Pharmacol, doi:10.1016/j.ejphar.2017.10.008
Zhu, Scholle, Kisthardt, Xie, Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E, Virology, doi:10.1016/j.virol.2022.04.005
{ 'indexed': {'date-parts': [[2024, 4, 25]], 'date-time': '2024-04-25T00:26:18Z', 'timestamp': 1714004778143}, 'reference-count': 0, 'publisher': 'MDPI AG', 'issue': '5', 'license': [ { 'start': { 'date-parts': [[2024, 4, 24]], 'date-time': '2024-04-24T00:00:00Z', 'timestamp': 1713916800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by/4.0/'}], 'funder': [ { 'name': 'NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious ' 'Diseases', 'award': ['PE00000007, INF-ACT']}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:p>Severe acute respiratory syndrome-related Coronavirus 2 (SARS-CoV-2) has infected ' 'more than 762 million people to date and has caused approximately 7 million deaths all around ' 'the world, involving more than 187 countries. Although currently available vaccines show high ' 'efficacy in preventing severe respiratory complications in infected patients, the high number ' 'of mutations in the S proteins of the current variants is responsible for the high level of ' 'immune evasion and transmissibility of the virus and the reduced effectiveness of acquired ' 'immunity. In this scenario, the development of safe and effective drugs of synthetic or ' 'natural origin to suppress viral replication and treat acute forms of COVID-19 remains a ' 'valid therapeutic challenge. Given the successful history of flavonoids-based drug discovery, ' 'we developed esters of substituted cinnamic acids with quercetin to evaluate their in vitro ' 'activity against a broad spectrum of Coronaviruses. Interestingly, two derivatives, the ' '3,4-methylenedioxy 6 and the ester of acid 7, have proved to be effective in reducing ' 'OC43-induced cytopathogenicity, showing interesting EC50s profiles. The ester of synaptic ' 'acid 7 in particular, which is not endowed with relevant cytotoxicity under any of the tested ' 'conditions, turned out to be active against OC43 and SARS-CoV-2, showing a promising EC50. ' 'Therefore, said compound was selected as the lead object of further analysis. When tested in ' 'a yield reduction, assay 7 produced a significant dose-dependent reduction in viral titer. ' 'However, the compound was not virucidal, as exposure to high concentrations of it did not ' 'affect viral infectivity, nor did it affect hCoV-OC43 penetration into pre-treated host ' 'cells. Additional studies on the action mechanism have suggested that our derivative may ' 'inhibit viral endocytosis by reducing viral attachment to host cells.</jats:p>', 'DOI': '10.3390/v16050665', 'type': 'journal-article', 'created': {'date-parts': [[2024, 4, 24]], 'date-time': '2024-04-24T14:18:36Z', 'timestamp': 1713968316000}, 'page': '665', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin', 'prefix': '10.3390', 'volume': '16', 'author': [ { 'given': 'Valeria', 'family': 'Manca', 'sequence': 'first', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Microbiology and Virology ' 'Unit, University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0002-1648-4519', 'authenticated-orcid': False, 'given': 'Annalisa', 'family': 'Chianese', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Experimental Medicine, University of Study of ' 'Campania “Luigi Vanvitelli”, Via Costantinopoli 16, 80138 ' 'Napoli, Italy'}]}, { 'given': 'Vanessa', 'family': 'Palmas', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Microbiology and Virology ' 'Unit, University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0003-4837-4477', 'authenticated-orcid': False, 'given': 'Federica', 'family': 'Etzi', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Biology and Genetic Unit, ' 'University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0001-7991-8700', 'authenticated-orcid': False, 'given': 'Carla', 'family': 'Zannella', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Experimental Medicine, University of Study of ' 'Campania “Luigi Vanvitelli”, Via Costantinopoli 16, 80138 ' 'Napoli, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0002-2470-9351', 'authenticated-orcid': False, 'given': 'Davide', 'family': 'Moi', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Life and Environmental Sciences, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0003-0443-2890', 'authenticated-orcid': False, 'given': 'Francesco', 'family': 'Secci', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Chemical and Geological Sciences, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0002-1971-3989', 'authenticated-orcid': False, 'given': 'Gabriele', 'family': 'Serreli', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Pathology Unit, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0002-6297-2687', 'authenticated-orcid': False, 'given': 'Giorgia', 'family': 'Sarais', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Life and Environmental Sciences, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0009-0000-0810-8460', 'authenticated-orcid': False, 'given': 'Maria Vittoria', 'family': 'Morone', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Experimental Medicine, University of Study of ' 'Campania “Luigi Vanvitelli”, Via Costantinopoli 16, 80138 ' 'Napoli, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0002-1576-6290', 'authenticated-orcid': False, 'given': 'Massimiliano', 'family': 'Galdiero', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Experimental Medicine, University of Study of ' 'Campania “Luigi Vanvitelli”, Via Costantinopoli 16, 80138 ' 'Napoli, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0002-2438-725X', 'authenticated-orcid': False, 'given': 'Valentina', 'family': 'Onnis', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Life and Environmental Sciences, University of ' 'Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0003-2961-3428', 'authenticated-orcid': False, 'given': 'Aldo', 'family': 'Manzin', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Microbiology and Virology ' 'Unit, University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}]}, { 'ORCID': 'http://orcid.org/0000-0002-3999-4263', 'authenticated-orcid': False, 'given': 'Giuseppina', 'family': 'Sanna', 'sequence': 'additional', 'affiliation': [ { 'name': 'Department of Biomedical Sciences, Microbiology and Virology ' 'Unit, University of Cagliari, Cittadella Universitaria, 09042 ' 'Monserrato, Italy'}]}], 'member': '1968', 'published-online': {'date-parts': [[2024, 4, 24]]}, 'container-title': 'Viruses', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.mdpi.com/1999-4915/16/5/665/pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 4, 24]], 'date-time': '2024-04-24T14:30:45Z', 'timestamp': 1713969045000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.mdpi.com/1999-4915/16/5/665'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 4, 24]]}, 'references-count': 0, 'journal-issue': {'issue': '5', 'published-online': {'date-parts': [[2024, 5]]}}, 'alternative-id': ['v16050665'], 'URL': 'http://dx.doi.org/10.3390/v16050665', 'relation': {}, 'ISSN': ['1999-4915'], 'subject': [], 'container-title-short': 'Viruses', 'published': {'date-parts': [[2024, 4, 24]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit